The global rise in the aging population, particularly in developed countries, has been a significant driver. As individuals age, they seek aesthetic solutions to address signs of aging, such as wrinkles, fine lines, and volume loss, contributing to the growing demand for aesthetic injectables.
In addition, the non-surgical and minimally invasive nature of aesthetic injectables has gained more attention. Many individuals prefer these procedures over surgical options due to reduced risks, shorter recovery times, and the ability to achieve noticeable results without undergoing extensive surgery.
Furthermore, innovations in the safety, efficacy, and longevity of aesthetic injectables enhance their appeal to both practitioners and patients. Ongoing advancements in technology, including improved product formulations and delivery systems contribute to the expansion of the market. The regulatory scrutiny, high cost of aesthetic procedure, and safety concerns can hamper the growth of aesthetic injectables industry.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global market size for aesthetic injectables was valued at USD 13.2 billion in 2023 and is anticipated to showcase 10.2% CAGR through 2032 owing to the increasing aging population seeking non-surgical solutions for signs of aging, and rising beauty consciousness across age groups.
The botulinum toxin segment is expected to reach USD 16.8 billion by 2032 owing to its high effectiveness in address dynamic wrinkles and fine lines of facial expressions.
North America market for aesthetic injectables accounted for USD 7.5 billion in 2023 and is projected to reach USD 16.5 billion by 2032 attributed to the well-established and advanced healthcare infrastructure, including numerous dermatology clinics, medical spas, and aesthetic centers.
Who are the key players in the global aesthetic injectables industry?